Dr. Benza is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
695 Merrick Ave
Westbury, NY 11590Phone+1 412-304-8866Fax+1 614-293-5614- Is this information wrong?
Summary
- Dr. Raymond Benza is a cardiologist in New York and is the CMO of PHope, a company founded to bring new interventional therapies for pulmonary hypertension. He received his medical degree from University of Florida College of Medicine. He specializes in heart failure, transplantation, mechanical circulatory support and pulmonary vascular diseases. His research is funded by the NIH.
Education & Training
- University of Alabama Medical CenterChief Residency, Cardiovascular Disease, 1996 - 1997
- University of Alabama Medical CenterFellowship, Cardiovascular Disease, 1993 - 1996
- University of Michigan Health SystemResidency, Internal Medicine, 1990 - 1992
- University of Michigan Health SystemInternship, Internal Medicine, 1989 - 1990
- University of Florida College of MedicineClass of 1989
Certifications & Licensure
- NY State Medical License 1992 - 2025
- OH State Medical License 2020 - 2024
- PA State Medical License 2008 - 2021
- AL State Medical License 1993 - 2008
- MI State Medical License 1991 - 1995
- American Board of Internal Medicine Advanced Heart Failure and Transplant Cardiology
Awards, Honors, & Recognition
- Association of University Cardiologists 2021
- Bob and Corrine Endowed Chair of Heart Failure The Ohio State University, 2020
- Best Doctors Pittsburgh 2013-2020
- Join now to see all
Clinical Trials
- REVEAL Registry™: Registry to Evaluate Early And Long-term PAH Disease Management Start of enrollment: 2006 Mar 01
- Safety and Efficacy Study of Ambrisentan in Subjects With Pulmonary Hypertension Start of enrollment: 2006 Aug 01
- Pharmacogenomics in Pulmonary Arterial Hypertension Start of enrollment: 2005 Jul 01
- Join now to see all
Publications & Presentations
PubMed
- The heart of the matter: Right heart imaging indicators for treatment escalation in pulmonary arterial hypertension.Paul Forfia, Raymond Benza, Michele D'Alto, Teresa De Marco, Jean M Elwing, Robert Frantz, Francois Haddad, Ronald Oudiz, Ioana R Preston, Stephan Rosenkranz, John Rya...> ;Pulmonary Circulation. 2023 Apr 1
- Treatment effects of pulmonary artery denervation for pulmonary arterial hypertension stratified by REVEAL risk score: Results from PADN-CFDA trial.Juan Zhang, Jing Kan, Yongyue Wei, Caojin Zhang, Zhenwen Yang, Heping Gu, Fenling Fan, Hong Gu, Qiguang Wang, Dujiang Xie, Gangcheng Zhang, Xiaomei Guo, Yuehui Yin, Bo...> ;The Journal of Heart and Lung Transplantation. 2023 Aug 1
- 1 citationsEuropean Society of Cardiology quality indicators for the care and outcomes of adults with pulmonary arterial hypertension. Developed in collaboration with the Heart F...Suleman Aktaa, Chris P Gale, Margarita Brida, George Giannakoulas, Gabor Kovacs, Yochai Adir, Raymond L Benza, Michael Böhm, Andrew Coats, Michele D'Alto, Pilar Escrib...> ;European Journal of Heart Failure. 2023 Apr 1
- Join now to see all
Journal Articles
- Clinical Research A Bayesian Model to Predict Survival After Left Ventricular Assist Device ImplantationStephen H Bailey, Srinivas Murali, Joseph G Rogers, Raymond Benza, Jeffrey J Teuteberg, Colleen K McIlvennan, Robert L Kormos, JoAnn Lindenfeld, ScienceDirect
Press Mentions
- OSU Wexner Launches 'Hospital-at-Home' Program for Patients with Heart FailureJanuary 28th, 2022
- WellSky® to Deliver in-Home Protocols for Patients with Heart FailureJanuary 27th, 2022
- United Therapeutics Details New Data Presented at CHEST Annual Meeting 2021October 21st, 2021
- Join now to see all
Grant Support
- VITA: Vascular Interventions/Innovations and Therapeutic AdvancesNational Heart, Lung and Blood Institute2014–Present
- Salivary Gland-Based Gene Therapy for Pulmonary Arterial HypertensionNational Heart, Lung and Blood Institute2013–Present
- Pulmonary Hypertension Breakthrough InitiativeAmerican Heart Association2008–Present
- Pharmacogenomics In Pulmonary Arterial HypertensionNational Heart, Lung, And Blood Institute2008
- Pharmacogenomics In Pulmonary Arterial HypertensionNational Heart, Lung, And Blood Institute2005–2007
- Genetic Determination Of Allograft VasculopathyNational Heart, Lung, And Blood Institute1998–2002
Committees
- Member, Advisory Council Organ Transplantation, HRSA 2010 - Present
- member, United Network of Organ Sharing Thoracic Council 2009 - Present
Professional Memberships
- Member
- Fellow
- Fellow
- Member
- Fellow
- Member
- International Society of Heart and Lung TransplantationBoard of Directors
- Member
Hospital Affiliations
- Heritage Valley Health SystemBeaver, Pennsylvania
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: